50 results
424B5
SEEL
Seelos Therapeutics Inc
30 Nov 23
Prospectus supplement for primary offering
4:58pm
skilled personnel;
the costs associated with being a public company;
the amount of revenue, if any, received from commercial sales of our product
424B5
SEEL
Seelos Therapeutics Inc
28 Nov 23
Prospectus supplement for primary offering
4:06pm
skilled personnel;
the costs associated with being a public company;
the amount of revenue, if any, received from commercial sales of our product
424B5
5bdt hwzi6rj0
25 Sep 23
Prospectus supplement for primary offering
6:02am
424B5
p55tpxh2p0559eezpf
12 May 22
Prospectus supplement for primary offering
8:30am
424B5
lgiqh2p 3y66m2l
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
ufsvdjnk zzpm7mq
19 May 21
Prospectus supplement for primary offering
4:08pm
424B5
281zw1v sqsn
26 Jan 21
Prospectus supplement for primary offering
5:11pm